{'fraction_non_alphanumeric': 0.019430051813471502, 'fraction_numerical': 0.007772020725388601, 'mean_word_length': 5.721739130434782, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Efficacy of intensive blue double-lamp phototherapy in the treatment of ABO incompatibility and idiopathic severe hemolytic jaundice].

Blue phototherapy is now generally accepted to be effective in the management of neonatal hyperbilirubinaemia. The response to phototherapy increases with increasing the skin surface area exposed to fluorescent illumination. We investigate the effects of "Intensive double direction phototherapy" (Double blue light 2 X 30 microW/cm2) in the treatment of neonatal hyperbilirubinaemia of 42 infants with ABO haemolytic diseases and "idiopathic" jaundice. We have found that serum bilirubin levels in newborn infants may be controlled more effectively with double light treatment and that the number of exchange transfusions was reduced.